No clinically relevant drug-drug interactions with semaglutide (Figure 3) were observed based on the evaluated medications. Figure 3 shows that they only tested 7 drugs: Metformin, S-warfarin, R-warfarin, Digoxin, Atorvastatin [Lipitor], Ethinylestradiol [used as a contraceptive in multiple brands), Levonorgestrel [Plan B]
Nevertheless, the STZ model used in this study is characterised by severe insulin deficiency and may not fully reflect the complex pathophysiology of type 2 diabetes mellitus
Side effects and unknown long-term outcomes Because of the relative newness of GLP-1 medications, long-term effects beyond a few years of use are unknown
Recommended dose: 10 to 15 grams of supplemental fiber daily, building up gradually over two to three weeks to avoid gas and cramping
MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study
"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations"